🇺🇸 FDA
Patent

US 11931335

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

granted A61KA61K31/00A61K31/122

Quick answer

US patent 11931335 (Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof) held by Amazentis SA expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/00, A61K31/122, A61K31/198, A61K31/205